Navigation Links
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Date:7/7/2010

EAST NORRITON, Pa., July 7 /PRNewswire-FirstCall/ -- Tengion Inc. (Nasdaq: TNGN) today announced that it has appointed Sunita B. Sheth, M.D., to the position of Chief Medical Officer, Vice President, Clinical and Regulatory Affairs. In this role, Dr. Sheth will be responsible for developing clinical development strategies, implementing clinical trials, and providing clinical translation insights to preclinical pipeline programs.

"We are extremely pleased to add Dr. Sheth to the Tengion team," stated Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion. "Her broad experience in multiple therapeutic areas, deep knowledge of early and late stage clinical development, and commitment to patient care will be invaluable to Tengion as we continue to advance our platform and product candidates."

Dr. Sheth most recently served as Vice President, Specialty Care Business Unit, for Pfizer as part of its acquisition of Wyeth. Prior to that, she spent four years at Wyeth, most recently as Vice President, Cardiovascular, Metabolic and Infectious Diseases. Before joining Wyeth, she held positions of increasing responsibility at AstraZeneca and GlaxoSmithKline since joining the industry in 1997. Her pharmaceutical development leadership experience covers multiple therapeutic areas and phases of development including approval of several INDs for drugs as well as the biologics FIX mab and OAP-189; the global regulatory submission of ximelagatran for multiple indications; and approval of an sNDA for Tygacil. 

"This is an exciting time for Tengion and I am very much looking forward to working closely with the man
'/>"/>

SOURCE Tengion Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. West Pharmaceutical Services, Inc. Appoints New Director
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Curemark Appoints Preeminent Pediatrics Gastroenterologist
9. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
10. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
11. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015 Research published today in ... Sciences (PNAS) demonstrates that technology invented by ... Casey Eye Institute can improve the clinical ... coherence tomography (OCT) angiography could largely replace current ... OHSU researchers found that OCT angiography ...
(Date:4/20/2015)... CAMBRIDGE, Mass. , April 20, 2015 /PRNewswire/ ... updated and final clinical results for the Phase ... doxorubicin, in HER2-positive metastatic breast cancer.  The results ... a clinical trials plenary oral session at the ... Meeting in Philadelphia, PA. ...
(Date:4/20/2015)... , April 20, 2015 This report analyzes the ... US$ Million by the following Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, ... Pressure Transducers. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts are provided ...
Breaking Medicine Technology:Study shows new technology may improve management of leading causes of blindness 2Study shows new technology may improve management of leading causes of blindness 3Study shows new technology may improve management of leading causes of blindness 4Study shows new technology may improve management of leading causes of blindness 5Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28
... SAN MATEO, Calif., July 1, 2011 Sonitus Medical, Inc., ... and removable hearing device to transmit sound via the teeth, ... for its SoundBite Hearing System. The FDA 510(k) clearance for ... device and marks another significant milestone for the company. ...
... Alere Inc. (NYSE: ALR ) ("Alere") ... facilities totaling $2.1 billion.  Jefferies Finance LLC, GE Capital ... acted as joint lead arrangers for the credit facilities, ... agent for the lenders under the credit facilities. ...
Cached Medicine Technology:Sonitus Medical Receives Second FDA Clearance for SoundBite™ Hearing System 2Alere Inc. Announces $2.1 Billion Credit Facilities 2
(Date:4/20/2015)... Global Lyme Alliance (GLA) announced today that its ... Hyatt Regency Greenwich, raised over $850,000 to fund research ... tick-borne diseases. , “We are extremely grateful to ... this year’s Gala such a success,” said Robert Kobre, ... initiatives to ultimately find a cure for Lyme ...
(Date:4/20/2015)... 20, 2015 Mauritius is a seemingly ... Located some 2,000 km (1,243 miles) off the southeastern ... cultural and religious melting pot where everyone lives together ... darker reality. Mauritius is riddled with drug abuse. In ... of opiate consumption of any nation in eastern Africa. ...
(Date:4/20/2015)... IL (PRWEB) April 20, 2015 ... Inc., has secured nationally-renowned Gastroenterologist Lawrence Kosinski, MD, ... , Dr. Kosinski brings a unique combination ... vision to the Mutare Health team ... improved communication, collaboration, and quality of care in ...
(Date:4/20/2015)... Novatus, a leading provider of ... service level to the growing European market by ... Paris. After a rigorous review process Novatus ... resilience, security and operational expertise, and extensive connectivity. ... as we expand our footprint and capabilities to ...
(Date:4/20/2015)... New York, New York (PRWEB) April 20, 2015 ... the trade association representing the U.S. health insurance ... as a result of the recent controversy involving ... In a letter to U.S. Senator Robert Casey ... the safety concerns surrounding uterine morcellation point to ...
Breaking Medicine News(10 mins):Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 2Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 3Health News:Voice For Humanity: Choolun Bhojoo leads the fight to rid Mauritius of a drug plague 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Novatus Expands into European Data Centers 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4
... delivering,albuterol, a fast-acting bronchial dilator, currently use propellants such ... December 31st,2009, or replacement HFA,s. Both propellants are also ... near-supersonic speeds. , ... of air by ejecting,the medication from a microfluidic pump ...
... without health insurance for all or some of 2007, according ... for Health Policy Research. , Drawing ... (CHIS), the policy brief,s authors found that 6.4 million Californians ... 2007, the most recent year for which comprehensive statewide data ...
... profiling, In-Stream profiling, data quality and MDM discovery solutions announces today ... (MMA), joining Microsoft Corp. and other key industry partners working together ... the Microsoft® platform. , ... Chicago, IL (PRWEB) December ...
... brand jeans appeal to people who seek intimacy in ... According to a new study in the Journal ... their brand choices. , In psychology, different relationship ... Vanitha Swaminathan, Karen M. Stilley (University of Pittsburgh), and ...
... particular gene could put brakes on killer disease, scientists ... produced by a particular gene may provide a new ... , Experiments at the Mayo Clinic College of Medicine ... down a key pathway in another gene that, in ...
... Mediocre or Near-Failing Grades , , ... care system mean more people than ever before are relying on ... mediocre C- grade for it support of emergency patients, according to ... Dr. Nicholas Jouriles, president of the American College of Emergency Physicians ...
Cached Medicine News:Health News:Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant 2Health News:Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant 3Health News:Nearly 6.4 million Californians lack health insurance, report shows 2Health News:AMB New Generation Data Empowerment Joins Mainframe Migration Alliance 2Health News:AMB New Generation Data Empowerment Joins Mainframe Migration Alliance 3Health News:Filling in the gaps: Personality types lead people to choose certain brands 2Health News:Pancreatic Cancer May Have a New Foe 2Health News:VIDEO from Medialink and ACEP: Nation's Failure to Support Emergency Patients Graded C- in National Report Card 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: